Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Ofev

Active ingredient: Nintedanib

Neutral reference profile for an independent medicine-access consultancy enquiry about Ofev (Nintedanib). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Ofev used for?

OFEV (Nintedanib) is a prescription medicine used to treat idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing interstitial lung disease (PF-ILD) with a chronic fibrotic phenotype.

These conditions cause lung scarring (fibrosis), making breathing difficult. OFEV is a tyrosine kinase inhibitor (TKI) that helps slow down the progression of fibrosis in the lungs, preventing further deterioration.

OFEV is taken as a capsule twice daily with food. Regular use can help maintain lung function, reduce breathlessness, and improve quality of life.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Ofev identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordOfev
Active ingredientNintedanib
Dosage formsoft capsules
Recorded options2
Directory areaPulmonology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 100 mg soft capsules · 60 capsules Catalogue organisation: axicorp Pharma B.V.
  2. 150 mg soft capsules · 60 capsules Catalogue organisation: PARANOVA PACK A/S

SERVICE BOUNDARY

Information checking and independent enquiry support for Ofev.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Ofev

01What is Ofev?

This directory record associates the brand name Ofev with the active ingredient Nintedanib. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Ofev strengths and packs are recorded?

The catalogue currently shows: 100 mg soft capsules · 60 capsules; 150 mg soft capsules · 60 capsules. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Ofev?

Catalogue records currently name: axicorp Pharma B.V., PARANOVA PACK A/S. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Ofev?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Ofev, payment request, stock guarantee or binding offer.

06Can I buy Ofev from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.